Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

PARTS iD Receives Notice Of Non-Compliance From NYSE American

Author: Benzinga Newsdesk | November 27, 2023 05:11pm

PARTS iD, Inc. (NYSE:ID) ("PARTS iD" or "the Company") today announced that it has received written notice (the "Notice") from the NYSE American LLC (the "NYSE American") indicating that the Company is not in compliance with the NYSE American's continued listing standards because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter September 30, 2023 (the "Form 10-Q"), which was due on November 20, 2023.

In accordance with Section 1007 of the NYSE American Company Guide, the Company will have six months from the date of the Notice (the "Initial Cure Period"), to file the Form 10-Q with the Securities and Exchange Commission (the "SEC"). If the Company fails to file the Form 10-Q during the Initial Cure Period, the NYSE American may, in its sole discretion, provide an additional six-month cure period (the "Additional Cure Period"). The Company can regain compliance with the NYSE American's continued listing standards at any time during the Initial Cure Period or Additional Cure Period, as applicable, by filing the Form 10-Q and any subsequent delayed filings with the SEC.

Reference is made to the Notification of Late Filing on Form 12b-25 filed by the Company with the SEC on November 14, 2023 (the "Form 12b-25") reporting that it required additional time to complete the Form 10-Q. Although the Company has dedicated significant resources to the completion of finalizing its consolidated financial statements and related disclosures for inclusion in the Form 10-Q, the Company was unable to file the Form 10-Q by November 20, 2023, the extension period provided by the Form 12b-25. Additional time is needed by the Company to complete its review of the financial statements included in the Form 10-Q in order to ensure a complete, accurate Form 10-Q. The Company intends to file the Form 10-Q as soon as practicable and in any event within the above-referenced six-month period.

The Notice has no immediate effect on the listing of the Company's securities on the NYSE American. There can be no assurance, however, that the Company will be able to regain compliance with the listing standards discussed above.

Posted In: ID

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist